1Ganem G,Tubiana-Hulin M,Fumoleau P, et al. Phase Ⅱ trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer[ J]. Ann Oncol,2003,14( 11 ) : 1623-1628.
2Lee SH, Chung MA, Quddus MR. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormonal receptor status in breast cance[J]. Am J Surg,2003,186(4) : 384-350.
3Susan H, Lee MD, Maureen A, et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer[J]. Am J Surg,2003,186 (4) :348-350.
4Piper GL, Patel NA, Malay MB, et al. Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status[ J]. Am J Surg,2004,70( 3 ) : 1103-1106.
1Mosselman S,Ploman J,Dijkema R.ER : indentification and characterisation of a novel human estrogen receptor[].FEBS Letters.1996
2Toniolo PG,Levitz M,Zeleniuch Jacquotte A,et al.A prospecitive study of endogenous estrogens and breast cancer in postmenopausal women[].Journal of the National Cancer Institute.1995
3Weisz A,Bresciani F.Estrogene regulation of proto-oncogenes coding for nuclear proteins[].Critical Reviews in Oncogenesis.1993
4Gaub MP,Bellard M,Scheuer I,et al.Activation of the ovalbumin gene by the estrogen receptor inyolves the Fos-Jun comples[].Cell.1990
5Umayahara Y,Kawamori R,Watada H,et al.Estrogene regulation of the insulin-like growth factor Ⅰ gene transcription involves an AP-1 enhancer[].Journal of Biological Chemistry.1994
6Speirs V,Parkes AT,Kerin MJ,et al.Coexpression of estrogen receptor and : poor prognostic factors in human breast cancer?[].Cancer Research.1999
7Dotzlaw H,Leygue E,Watsonn PH,et al.Estrogen receptor messenger RNA exprssion in human breast tumor biopsies: relationship to steroid status and regulation by progestins[].Cancer Research.1999
8Saric T,Shain SA.Semiquantitative RT-PCR: enhancement of assay accuracy and reproducibility[].Biotechniques.1997
9Paech K,Webb P,Kuiper GG,et al.Differential ligand activation of estrogen receptors ER and ER at AP1 sites[].Science.1997
10Honig S.Treatment of metastatic disease[].In: Harris J Lippman M Mellman S eds Diseases of the breast.1996
3Rosell R, Gomez-Codina J, Camps C, et al. Pieresectional chemotherapy in stage m A non-small-cell lung cancer : a 7-year assessment of a randomized controlled trial [ J]. Lung Cancer, 1999,26( 1 ) :7- 14.
4Spasova I, Petera J, Hytych V. The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage Ⅲ non-small-cell lung cancer [ J ]. Neoplasma,2002,49 (3) : 189-196.
5Betticher DC, Hsu Schmitz SF, Totsch M, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage ⅢA pN2 non-small-cell lung cancer: a multicenter phase Ⅱ trial [ J ]. J Clin Oncol, 2003, 21 (9) :1752-1759.
6Bear HD, Anderson S, Smith RE, et al. Sequential preoperative or postoperative docetaxel added to preperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B 27[J]. Clin Oncol,2006,24: 2019- 2027.
7Piper GL,Patel NA, Malay MB,et al. Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status[J]. Am J Surg,2004,70(12) :1103.
8Taueher S, Rudas M, Gnant M,et al. Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy[J]. Endocr Relat Cancer, 2003,10: 91-98.
9Faneyte IF, Schrama JG, Peterse JL, et al. Breast cancer response to neoadjuvant chemotherapy: predictive marker and relation with outcome[J]. Br J Cancer, 2003,88(3) : 4o6.
10Campiglio M, Somenzi G, Olgiati C, et al. Role of proliferation in HER-2 status predicted response to doxorubicin[J]. Int J Can, 2003, 105(4) :568-573.
